RVTYRevvity, Inc.
111.26USD+0.04%Mkt Cap: 12.41B $P/E: 53.49

Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and servi…

Industry Peers

Diagnostics & Research
Screen all
vs Diagnostics & Research
P/E
Pricier
P/B
Cheaper
Div Yield
Higher
1M Perf
Avg
TMO
Thermo Fisher Scientific Inc.
$186.32BUSDP/E 27.6
DHR
Danaher Corporation
$134.82BUSDP/E 36.8
LONN
Lonza Group AG
$43.51BUSDP/E 42.0
IDXX
IDEXX Laboratories, Inc.
$41.53BUSDP/E 38.7
NTRA
Natera, Inc.
$38.88BUSD
A
Agilent Technologies, Inc.
$37.53BUSDP/E 26.7
WAT
Waters Corporation
$36.82BUSDP/E 47.7
IQV
IQVIA Holdings Inc.
$32.25BUSDP/E 24.0
ILMN
Illumina, Inc.
$26.60BUSDP/E 31.9
MTD
Mettler-Toledo International Inc.
$25.82BUSDP/E 30.0
DGX
Quest Diagnostics Incorporated
$23.46BUSDP/E 23.4
LH
Labcorp Holdings Inc.
$22.96BUSDP/E 24.8
GH
Guardant Health, Inc.
$19.89BUSD
MEDP
Medpace Holdings, Inc.
$15.12BUSDP/E 33.3
ERF
Eurofins Scientific SE
$12.91BUSDP/E 26.9
CRL
Charles River Laboratories International, Inc.
$10.92BUSD
BIM
bioMérieux S.A.
$8.81BUSDP/E 20.6
TWST
Twist Bioscience Corporation
$6.41BUSD
BLLN
BillionToOne, Inc.
$5.52BUSDP/E 222.2
SHC
Sotera Health Company
$5.06BUSDP/E 43.3
RDNT
RadNet, Inc.
$4.85BUSD
VCYT
Veracyte, Inc.
$4.69BUSDP/E 54.4
DIA
DiaSorin S.p.A.
$3.65BUSDP/E 25.7
ADPT
Adaptive Biotechnologies Corporation
$3.43BUSD
GRAL
GRAIL, Inc.
$2.93BUSD
WGS
GeneDx Holdings Corp.
$2.04BUSD
NEO
NeoGenomics, Inc.
$1.90BUSD
VIMIAN
Vimian Group AB (publ)
$1.48BUSDP/E 37.4
DIA
Diagnostyka S.A.
$1.48BUSDP/E 22.4
CDNA
CareDx, Inc.
$1.47BUSD
PSNL
Personalis, Inc.
$1.40BUSD
OPK
OPKO Health, Inc.
$1.13BUSD
CBAV
Clínica Baviera, S.A.
$1.01BUSDP/E 21.1
CSTL
Castle Biosciences, Inc.
$723.37MUSD
LBIRD
Lumibird SA
$615.20MUSDP/E 40.1
FLGT
Fulgent Genetics, Inc.
$582.78MUSD
MYGN
Myriad Genetics, Inc.
$539.30MUSD
VOX
Voxel S.A.
$297.38MUSDP/E 3.0
EDT
Spectral Medical Inc.
$282.06MUSD
BDSX
Biodesix, Inc.
$233.52MUSD
IMDX
Insight Molecular Diagnostics Inc.
$190.51MUSD
SLV
Selvita S.A.
$147.80MUSD
XGN
Exagen Inc.
$112.34MUSD
ALECR
Eurofins-Cerep SA
$94.30MUSDP/E 18.2
BIOPOR
BioPorto A/S
$77.88MUSD
PANG
Pangaea Oncology, S.A.
$58.94MUSD
PRPO
Precipio, Inc.
$44.26MUSD
ABDX
Abingdon Health Plc
$27.97MUSD
NN6
NanoRepro AG
$27.15MUSD
GDR
genedrive plc
$22.69MUSD
SENZA
SenzaGen AB
$17.60MUSD
IMMNOV
Immunovia AB (publ)
$12.55MUSD
BMX
BioMaxima S.A.
$10.07MUSDP/E 63.2
ALPRE
Predilife S.A.
$9.85MUSD
VRCI
Verici Dx plc
$9.02MUSD
XWEL
XWELL, Inc.
$8.78MUSD
NDRA
ENDRA Life Sciences Inc.
$6.77MUSD
PRM
Proteome Sciences plc
$6.29MUSD
AVCR
Avricore Health Inc.
$5.98MUSD
BIAF
bioAffinity Technologies, Inc.
$5.10MUSD
OBD
Oxford BioDynamics Plc
$4.66MUSD
ISPC
iSpecimen Inc.
$3.81MUSD
JUMP
Leveljump Healthcare Corp.
$3.86MUSDP/E 2.8
TELO
Telo Genomics Corp.
$2.93MUSD
NOTV
Inotiv Inc
$2.79MUSD
PROGEN
Prostatype Genomics AB (publ)
$2.43MUSD
PRPH
ProPhase Labs, Inc.
$1.29MUSD
MBI-H
Many Bright Ideas Technologies Inc.
$314.2KUSDP/E Infinity
TTOO
T2 Biosystems, Inc.
$14.0KUSD
Indicators:|

Key Statistics

Company
Market Cap12.41B $
Enterprise Value14.90B $
Revenue (TTM)2.90B $
Gross Profit1.56B $
Net Income (TTM)241.20M $
Revenue/Share25.36 USD
Last Price111.26 USD
Fiscal Year EndDec 2025
MR QuarterApr 2026
Employees11.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN
Valuation
P/E (Trailing)53.49
P/E (Forward)19.09
PEG0.69
EV/EBITDA17.42
EV/Revenue5.13
P/S4.28
P/B1.73
EPS (TTM)2.08
EPS (Forward)5.83
52W Range
81.2281% of range118.30
52W High118.30 USD
52W Low81.22 USD
Profitability
Gross Margin54.77%
Oper. Margin12.35%
EBITDA Margin29.47%
Profit Margin8.45%
ROE3.33%
ROA1.98%
Growth
Revenue Growth7.00%
Earnings Growth3.50%
Cash Flow & Leverage
Operating CF582.93M $
CapEx (TTM)73.52M $
FCF Margin17.54%
FCF Yield4.10%
Net Debt2.49B $
Net Debt/EBITDA2.91
Balance Sheet
Debt/Equity0.47
Current Ratio1.72
Quick Ratio1.25
Book Value/Sh64.34 USD
Cash/Share7.712 USD
Dividends
Fwd Div Rate0.2800 USD
Trail. Div Rate0.2800 USD
Div. Yield0.25%
5Y Avg Yield0.24%
Payout Ratio13.46%
Ex-Div DateJul 17, 2026
Pay DateAug 7, 2026
Splits
Last Split2:1
Split DateJun 4, 2001
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)113.73 USD
Upside (mean)+2.2%
Target Range90.00 USD145.00 USD
$90.00+2.2% to mean$145.00
# Analysts15
Ownership
Shares Out.111.56M
Float102.14M
Insiders0.36%
Institutions105.81%
Short Interest
Short Ratio5.7d
Short % Float11.17%
Short % Out.7.46%
Shares Short8.32M
Short (prev mo.)9.52M
Technical
SMA 5097.36 (+14.3%)
SMA 20096.19 (+15.7%)
Beta1.11
S&P 52W Chg20.05%
Avg Vol (30d)1.13M
Avg Vol (10d)1.71M
Technical Indicators
RSI (14)65.2
MACD3.5208
MACD Signal2.4629
MACD Hist.+1.0579
BB Upper113.21 USD
BB Middle103.05 USD
BB Lower92.89 USD
BB Width19.72%
ATR (14)4.209 USD
Vol Ratio (20d)1.96x